/Johnson%20%26%20Johnson%20logo%20on%20phone-by%20Allmy%20via%20Shutterstock.jpg)
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a diversified business model. With a market cap of $368.7 billion, Johnson & Johnson operates through pharmaceuticals, medical devices and consumer products divisions.
Companies worth $200 billion or more are generally described as "mega-cap stocks." JNJ fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the healthcare sector. The company’s extensive operations span numerous countries, spanning the Americas, EMEA, and the Indo-Pacific.
